دورية أكاديمية

Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores.

التفاصيل البيبلوغرافية
العنوان: Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH-MSK scores.
المؤلفون: Sasaki K; Department of Surgery, Cleveland Clinic, Cleveland, OH, USA., Gagnière J; Service de Chirurgie Digestive, CHU Clermont-Ferrand, Inserm, Université Clermont Auvergne, Clermont-Ferrand, France., Dupré A; Service de Chirurgie Digestive, CHU Clermont-Ferrand, Inserm, Université Clermont Auvergne, Clermont-Ferrand, France., Ardiles V; HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., O'Connor JM; Alexander Fleming Institute, Buenos Aires, Argentina., Wang J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Moro A; Department of Surgery, Cleveland Clinic, Cleveland, OH, USA., Morioka D; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Buettner S; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gau L; Service de Chirurgie Digestive, CHU Clermont-Ferrand, Inserm, Université Clermont Auvergne, Clermont-Ferrand, France., Ribeiro M; Service de Chirurgie Digestive, CHU Clermont-Ferrand, Inserm, Université Clermont Auvergne, Clermont-Ferrand, France., Wagner D; Department of General Surgery, Medical University of Graz, Graz, Austria., Andreatos N; Department of Surgery, Cleveland Clinic, Cleveland, OH, USA., Løes IM; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Fitschek F; Department of General Surgery, Medical University of Vienna, Vienna, Austria., Kaczirek K; Department of General Surgery, Medical University of Vienna, Vienna, Austria., Lønning PE; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Kornprat P; Department of General Surgery, Medical University of Graz, Graz, Austria., Poultsides G; Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA., Kamphues C; Department of General, Visceral and Vascular Surgery, Charite Campus Benjamin Franklin, Berlin, Germany., Imai K; Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan., Baba H; Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan., Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kwon CHD; Department of Surgery, Cleveland Clinic, Cleveland, OH, USA., Aucejo FN; Department of Surgery, Cleveland Clinic, Cleveland, OH, USA., de Santibañes E; HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Kreis ME; Department of General, Visceral and Vascular Surgery, Charite Campus Benjamin Franklin, Berlin, Germany., Margonis GA; Department of General, Visceral and Vascular Surgery, Charite Campus Benjamin Franklin, Berlin, Germany.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
المصدر: Journal of hepato-biliary-pancreatic sciences [J Hepatobiliary Pancreat Sci] 2021 Jul; Vol. 28 (7), pp. 581-592. Date of Electronic Publication: 2021 Apr 24.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley Japan Country of Publication: Japan NLM ID: 101528587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1868-6982 (Electronic) Linking ISSN: 18686974 NLM ISO Abbreviation: J Hepatobiliary Pancreat Sci Subsets: MEDLINE
أسماء مطبوعة: Publication: 2014- : Tokyo : Wiley Japan
Original Publication: Tokyo : Springer Japan
مواضيع طبية MeSH: Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/surgery , Liver Neoplasms*/genetics , Liver Neoplasms*/surgery, Hepatectomy ; Humans ; Prognosis ; Retrospective Studies
مستخلص: Introduction: Two novel clinical risk scores (CRS) that incorporate KRAS mutation status were developed: modified CRS (mCRS) and GAME score. However, they have not been tested in large national and international cohorts. The aim of this study was to validate the prognostic discrimination utility and determine the clinical usefulness of the two novel CRS.
Methods: Patients undergoing hepatectomy for CRLM (2000-2018) in 10 centers were included. The discriminatory abilities of mCRS, GAME, and Fong CRS were evaluated using Harrell's C-index and Akaike's Information Criterion.
Results: In the entire cohort, the C-index of the GAME score (0.61) was significantly higher than those of Fong score (0.57) and mCRS (0.54), while the C-Index of mCRS was significantly lower than that of Fong score. When we compared the models in the various geographical regions, the C-index of GAME score was significantly higher than that of mCRS in North America, Europe, and South America. The AIC of Fong score, mCRS, and GAME score were 14 405, 14 447, and 14 319, respectively.
Conclusion: In conclusion, using the largest and most heterogenous population of CRLM patients with known KRAS status, this independent, external validation demonstrated that the GAME score outperforms both the traditional Fong score and mCRS.
(© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
References: Jarnagin WR. Clinical scoring systems for stratifying risk after resection of hepatic colorectal metastases: still relevant? Ann Surg Oncol. 2011;18:2711-3.
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318; discussion 18-21.
Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291-9.
Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg. 2007;246:183-91.
Gomez D, Cameron IC. Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford). 2010;12:227-38.
Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125-35.
Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, van Heerden JA, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216:493-504; discussion-5.
Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505-10; discussion 11.
Reissfelder C, Rahbari NN, Koch M, Ulrich A, Pfeilschifter I, Waltert A, et al. Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol. 2009;16:3279-88.
Ayez N, Lalmahomed ZS, van der Pool AE, Vergouwe Y, van Montfort K, de Jonge J, et al. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol. 2011;18:2757-63.
Roberts KJ, White A, Cockbain A, Hodson J, Hidalgo E, Toogood GJ, et al. Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg. 2014;101:856-66.
Beamish P, Lemke M, Li J, Dixon E, Abraham MT, Hernandez-Alejandro R, et al. Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort. HPB (Oxford). 2017;19:675-81.
Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269:120-6.
Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, et al. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105:1210-20.
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, Andreatos N, Tzanninis IG, Sasaki K, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis. Ann Surg. 2018;267:1047-55.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102:148-58.
Stuart EA, Azur M, Frangakis C, Leaf P. Multiple imputation with large data sets: a case study of the Children's Mental Health Initiative. Am J Epidemiol. 2009;169:1133-9.
Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 2004.
Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol. 2013;13:33.
Gasser E, Braunwarth E, Riedmann M, Cardini B, Fadinger N, Presl J, et al. Primary tumour location affects survival after resection of colorectal liver metastases: a two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score. PLoS One. 2019;14:e0217411.
Wang XY, Zhang R, Wang Z, Geng Y, Lin J, Ma K, et al. Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases. Br J Surg. 2019;106:1747-60.
Jing L, Su L, Ring BZ. Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review. PLoS One. 2014;9:e97522.
Sasaki K, Morioka D, Conci S, Margonis GA, Sawada Y, Ruzzenente A, et al. The tumor burden score: a new, "Metro-ticket" prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267:132-41.
Sasaki K, Margonis GA, Andreatos N, Wilson A, Gani F, Amini N, et al. Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications? HPB (Oxford). 2016;18:1000-9.
Leung U, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, et al. Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection. Ann Surg. 2017;265:158-65.
Andreatos N, Ronnekleiv-Kelly S, Margonis GA, Sasaki K, Gani F, Amini N, et al. From bench to bedside: clinical implications of KRAS status in patients with colorectal liver metastasis. Surg Oncol. 2016;25:332-8.
Margonis GA, Buettner S, Andreatos N, Wagner D, Sasaki K, Barbon C, et al. Prognostic factors change over time after hepatectomy for colorectal liver metastases: a multi-institutional, international analysis of 1099 patients. Ann Surg. 2019;269:1129-37.
Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, et al. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res. 2019;25:5843-51.
Kamphues C, Andreatos N, Kruppa J, Buettner S, Wang J, Sasaki K, et al. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: an international, multi-institutional study. J Surg Oncol. 2021;123:939-48.
فهرسة مساهمة: Keywords: KRAS; clinical risk score; colorectal liver metastases; hepatectomy; long-term outcome
تواريخ الأحداث: Date Created: 20210402 Date Completed: 20211015 Latest Revision: 20211015
رمز التحديث: 20231215
DOI: 10.1002/jhbp.963
PMID: 33797866
قاعدة البيانات: MEDLINE
الوصف
تدمد:1868-6982
DOI:10.1002/jhbp.963